2020
DOI: 10.1016/j.ijantimicag.2020.106079
|View full text |Cite
|
Sign up to set email alerts
|

Dissemination of a ‘rare’ extended-spectrum β-lactamase gene blaSFO-1 mediated by epidemic clones of carbapenemase-producing Enterobacter hormaechei in China

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
19
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
2

Relationship

2
6

Authors

Journals

citations
Cited by 15 publications
(21 citation statements)
references
References 23 publications
2
19
0
Order By: Relevance
“…Recently, reports about the coexistence of a rare ESBL gene bla SFO−1 and carbapenemase genes were increased (Zhou et al, 2020). New Delhi metallo-lactamase (NDM-1), a β-lactam hydrolase, constitutes a critical and growingly important medical issue, since its resistance trait compromises the efficacy of almost all lactams (except aztreonam), including carbapenems (Dortet et al, 2014).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Recently, reports about the coexistence of a rare ESBL gene bla SFO−1 and carbapenemase genes were increased (Zhou et al, 2020). New Delhi metallo-lactamase (NDM-1), a β-lactam hydrolase, constitutes a critical and growingly important medical issue, since its resistance trait compromises the efficacy of almost all lactams (except aztreonam), including carbapenems (Dortet et al, 2014).…”
Section: Introductionmentioning
confidence: 99%
“…New Delhi metallo-lactamase (NDM-1), a β-lactam hydrolase, constitutes a critical and growingly important medical issue, since its resistance trait compromises the efficacy of almost all lactams (except aztreonam), including carbapenems (Dortet et al, 2014). Compared with other broad-spectrum β-lactamase, the bla SFO−1 gene is a low-incidence antimicrobial resistance gene and usually not subject to systematic monitoring, which puts it at risk of being missed (Zhao et al, 2015;Zhou et al, 2020). With the increase of infections caused by carbapenemaseproducing bacteria and the lack of novel antibiotics (Gurjar, 2015), polymyxins have become the last-resort therapies in the treatment of infections caused by this kind of multidrug-resistant (MDR) bacterial (Olaitan et al, 2014;Yilmaz et al, 2016).…”
Section: Introductionmentioning
confidence: 99%
“…Strains 1847 and 13755-1A, present in IncFII (pECLA) plasmid (Table 5), are associated with antibiotic resistance genes in Cronobacter, such as carbapenemase genes ∆intI1bla IMP-26 , bla CSA , bla CMA , and IS26 flanking bla SFO-1 [77,78].…”
Section: Resultsmentioning
confidence: 99%
“…Infections related to multidrug-resistant bacteria (MDR) have led to the use of broad-spectrum antibiotics such as third and fourth generation cephalosporins and carbapenems, causing an increase on selective pressure that has favored the proliferation and dissemination of resistant strains [4,5]. Extended-spectrum beta-lactamases (ESBL) producing Enterobacteriaceae are considered by the World Health Organization (WHO) as priority microorganisms for the development of new antibiotics, as well as for microbial resistance monitoring [6]. ESBL production confers resistance to most penicillins, to rst, second, and third generation cephalosporins and to monobactams [7,8,9].…”
Section: Introductionmentioning
confidence: 99%
“…ESBLs groups includes nine structural families: TEM, SHV, CTX-M, PER, VEB, GES, TLA, BES and OXA [11]. The TEM, SHV and CTX-M families are the most prevalent worldwide reported in hospital and community infections [6,12,13]. ESBLs contained in conjugative plasmids facilitate their mobility through horizontal gene transfer [11,14,15] and in turn, these plasmids may contain resistance related genes to other antibiotics, such as quinolones, aminoglycosides, tetracyclines and even colistin, which increases the chances of failure in treatment schemes [16,17,18].…”
Section: Introductionmentioning
confidence: 99%